Justin Davies
CardioMonaco / Cerebria.AI
Monaco
Justin Davies is an interventional cardiologist, inventor of iFR (Instantaneous Wave-free Ratio) and CEO of Cerebria AI. Trained at Hammersmith Hospital, Imperial College London, he has published over 500 peer-reviewed papers, including in the New England Journal of Medicine and The Lancet, and holds 20 patents. As co-principal investigator of DEFINE-FLAIR, he helped make iFR a global standard in coronary physiology. He is a board member of Monaco Cardio at the Princess Grace Hospital, Monaco.
Justin Davies is an interventional cardiologist, a board member of Monaco Cardio at the Princess Grace Hospital, Monaco, and CEO of Cerebria AI. He has more than 15 years of experience as a leading educator in cardiology. His clinical and academic career was built at Hammersmith Hospital, Imperial College London, where he earned an international reputation for innovation in cardiovascular medicine. He invented iFR (Instantaneous Wave-free Ratio) and, as co-principal investigator of the DEFINE-FLAIR trial, helped establish it as a globally adopted standard in coronary physiology. He has published more than 500 peer-reviewed papers, including landmark studies in the New England Journal of Medicine and The Lancet, holds 20 patents in cardiovascular medicine and technology, and has mentored 15 PhD students. At Cerebria AI, he leads the development of next-generation AI-powered cardiovascular imaging and physiology tools that bring artificial intelligence into frontline cardiology to support clinical decision-making and improve patient outcomes. Combining deep clinical expertise with an entrepreneurial track record, he continues to take new technologies through funding, regulatory approval and commercialisation, with the aim of transforming cardiovascular care worldwide.